Toxicokinetics of perfluoroalkyl carboxylates with different carbon chain lengths in mice and humans

DOI Web Site Web Site Web Site PubMed 被引用文献9件 参考文献38件
  • Fujii Yukiko
    Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine
  • Niisoe Tamon
    Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine
  • Harada Kouji H.
    Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine
  • Uemoto Shinji
    Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University Graduate School of Medicine
  • Ogura Yasuhiro
    Transplantation Surgery, Nagoya University Hospital
  • Takenaka Katsunobu
    Department of Neurosurgery, Takayama Red Cross Hospital
  • Koizumi Akio
    Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine

書誌事項

タイトル別名
  • Toxicokinetics of perfluoroalkyl carboxylic acids with different carbon chain lengths in mice and humans

この論文をさがす

抄録

Objectives: Perfluoroalkyl carboxylic acids (PFCAs) consist of analogs with various carbon chain lengths. Their toxicokinetics have remained unexplored except in the case of perfluorooctanoic acid (8 carbon chemicals). This study aimed to investigate the toxicokinetics of PFCAs with six to fourteen carbon atoms (C6 to C14) in mice and humans. Methods: We applied a two-compartment model to mice administered PFCAs intravenously or by gavage. The time courses of the serum concentration and tissue distribution and elimination were evaluated for 24 hours after treatment. For human samples, urine from healthy volunteers, bile from patients who underwent biliary drainage, and cerebral spinal fluid (CSF) from brain drainage were collected. Results: The mouse experiment showed that short-chained PFCAs (C6 and C7) were rapidly eliminated in the urine, whereas long-chain PFCAs (C8 to C14) accumulated in the liver and were excreted slowly in feces. Urinary clearance of PFCAs in humans also decreased with increasing alkyl chain lengths, while biliary clearances increased. C9 to C10 had the smallest total clearance for both mice and humans. However, disparities existed in the magnitude of the total clearance between mice and humans. A slightly higher partition ratio (brain/serum) was observed for long-chained PFCAs in mice, but this was not observed in the corresponding partition ratio in humans (CSF/serum). Conclusions: The large sequestration volumes of PFCAs in the liver seem to be attributable to the liver's large binding capacity in both species. This will be useful in evaluating PFCA bioaccumulation in other species.(J Occup Health 2015; 57: 1–12)

収録刊行物

被引用文献 (9)*注記

もっと見る

参考文献 (38)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ